drugset / Trial / NCT00650273
Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan's azithromycin 600 mg tablets to Pfizer's Zithromax® 600 mg tablets following a single, oral 600 mg (1 x 600 mg) dose administered under fasting conditions.
Timeline
- Start
- 2005-04
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 600 mg | Oral |
Indications
No indication recorded.